AbbVie Inc. (ABBV)

Statement of Cash Flows
Quarterly Data

Difficulty: Beginner

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

AbbVie Inc., Consolidated Statement of Cash Flows (quarterly data)

USD $ in millions

	3 months ended	Jun 30, 2019		Mar 31, 2019		Dec 31, 2018		Sep 30, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014
	Net earnings
	Depreciation
	Amortization of intangible assets
	Change in fair value of contingent consideration liabilities
	Stock-based compensation
	Upfront costs and milestones related to collaborations
	Devaluation loss related to Venezuela
	Intangible asset impairment
	Impacts related to U.S. tax reform
	Other, net
	Accounts receivable
	Inventories
	Prepaid expenses and other assets
	Accounts payable and other liabilities
	Changes in operating assets and liabilities
	Adjustments to reconcile net earnings to net cash from operating activities
	Cash flows from operating activities
	Acquisitions of businesses, net of cash acquired
	Other acquisitions and investments
	Acquisitions of property and equipment
	Transfers to restricted cash
	Purchases of investment securities
	Sales and maturities of investment securities
	Other
	Cash flows from investing activities
	Net change in commercial paper borrowings
	Proceeds from issuance of other short-term borrowings
	Repayments of other short-term borrowings
	Proceeds from issuance of long-term debt
	Repayments of long-term debt and lease obligations
	Debt issuance costs
	Dividends paid
	Purchases of treasury stock
	Proceeds from the exercise of stock options
	Payments of contingent consideration liabilities
	Net transactions with Abbott Laboratories, excluding non-cash items
	Other, net
	Cash flows from financing activities
	Effect of exchange rate changes on cash and equivalents
	Net change in cash and equivalents

Item	Description	The company
Cash flows from operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	AbbVie Inc.’s cash flows from operating activities declined from Q4 2018 to Q1 2019 and from Q1 2019 to Q2 2019.
Cash flows from investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	AbbVie Inc.’s cash flows from investing activities increased from Q4 2018 to Q1 2019 but then slightly declined from Q1 2019 to Q2 2019.
Cash flows from financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	AbbVie Inc.’s cash flows from financing activities declined from Q4 2018 to Q1 2019 but then increased from Q1 2019 to Q2 2019 exceeding Q4 2018 level.

	AbbVie Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

AbbVie Inc. (ABBV)

Statement of Cash FlowsQuarterly Data

Statement of Cash Flows
Quarterly Data